Could an asthma drug help heal hearts after a heart attack?

NCT ID NCT07537868

Recruiting now Disease control Sponsor: October 6 University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether montelukast, a common asthma drug, can reduce inflammation and limit heart muscle damage in people who have just had a heart attack. Eighty adults aged 30-75 will receive either montelukast or a placebo for 4 weeks. Researchers will measure changes in blood markers of inflammation and heart injury to see if the drug offers any protective benefit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Montelukast 10 mg oral tablet
What this could lead to: If it works, this could point toward a new, inexpensive way to limit heart damage and improve recovery after a heart attack.
What could go wrong: This is a small, early-phase trial. Montelukast is not proven for heart conditions, and the results may not lead to a new treatment. There is also a risk of side effects like headache or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION (AMI)

Contacts and locations

Locations

Mansoura Faculty of Medicine hospital
RECRUITING

Al Mansurah, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.